Free Trial

LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts

LeMaitre Vascular logo
$103.44 -0.30 (-0.29%)
(As of 11/20/2024 ET)

LeMaitre Vascular Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 25Estimated
Actual EPS
(Oct. 31)
$0.49 Beat By $0.05
Consensus EPS
(Oct. 31)
$0.44

LeMaitre Vascular posted Q3 2024 earnings on October 31, 2024, reporting an EPS of $0.49, which beat analysts' consensus estimates of $0.44 by $0.05. Quarterly revenue rose 15.6% year-over-year to $54.82 million, above the consensus estimate of $53.50 million. With a trailing EPS of $1.83 and a P/E Ratio of 56.52, LeMaitre Vascular's earnings are expected to grow 11.34% next year, from $1.94 to $2.16 per share.

LMAT Upcoming Earnings

LeMaitre Vascular's next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules.

Get LeMaitre Vascular Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LeMaitre Vascular and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LMAT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LMAT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

LeMaitre Vascular Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.40$0.40$0.400.360 - 0.410
Q2 20241$0.47$0.47$0.470.450 - 0.500
Q3 20241$0.40$0.40$0.400.420 - 0.460
Q4 20242$0.43$0.49$0.460.470 - 0.510
FY 20245$1.70$1.76$1.73 
Q1 20252$0.50$0.54$0.52 
Q2 20252$0.51$0.53$0.52 
Q3 20252$0.51$0.55$0.53 
Q4 20252$0.47$0.53$0.50 
FY 20258$1.99$2.15 $2.07

LeMaitre Vascular Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/25/2025
(Estimated)
------- 
10/31/2024Q3 2024$0.44$0.49+$0.05$0.49$53.50M$54.82M        
8/1/2024Q2 2024$0.47$0.52+$0.05$0.52$54.98M$55.85M        
5/2/2024Q1 2024$0.39$0.44+$0.05$0.44$51.50M$53.48M        
2/27/2024Q4 2023$0.36$0.38+$0.02$0.38$49.01M$48.90M        
11/1/2023Q3 2023$0.31$0.33+$0.02$0.33$47.58M$47.40M      
8/1/2023Q2 2023$0.32$0.37+$0.05$0.38$48.29M$50.12M  
5/2/2023Q1 2023$0.25$0.27+$0.02$0.27$43.54M$47.08M        
2/23/2023Q4 2022$0.26$0.25 -$0.01$0.25$40.99M$41.00M        

LeMaitre Vascular Earnings - Frequently Asked Questions

LeMaitre Vascular has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on LMAT's earnings history.

LeMaitre Vascular updated its FY 2024 earnings guidance on Thursday, October, 31st. The company provided EPS guidance of 1.910-1.960 for the period, compared to the consensus EPS estimate of 1.850. The company issued revenue guidance of $219.0 million-$221.0 million, compared to the consensus revenue estimate of $218.3 million.

In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) reported $0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $0.44 by $0.05. Learn more on analysts' earnings estimate vs. LMAT's actual earnings.

The conference call for LeMaitre Vascular's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for LeMaitre Vascular's latest earnings report can be read online.
Read Transcript

LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $193.48 million.

LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $30.10 million. LMAT has generated $1.83 earnings per share over the last four quarters.

LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 56.52 and a forward price-to-earnings ratio of 53.32. The price/earnings-to-growth ratio is 2.54.

LeMaitre Vascular's earnings are expected to grow from $1.94 per share to $2.16 per share in the next year, which is a 11.34% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:LMAT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners